Parallax Health Sciences Announces Increased Customer Acquisition in Both Management and Diagnostics Divisions
April 09, 2020 10:10 ET
|
Parallax Health Sciences, Inc.
Company Receives Over $10 million of Telehealth and Medical Supply Contracts from Coast to Coast NEW YORK, NY, April 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health...
Parallax Diagnostics Partners with CURE Pharmaceuticals to Distribute Individually Sealed CUREfilm® D for Medical and Critical Services Workers
April 07, 2020 10:21 ET
|
Parallax Health Sciences, Inc.
COVID-19 Coronavirus Infection Risk May be Reduced by Weekly Dose of Vitamin D3 NEW YORK, NY, April 07, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB:...
Parallax Health Sciences Announces Patent Enforcement Initiative
January 06, 2020 07:00 ET
|
Parallax Health Sciences, Inc.
Over $500 Million in Potential Infringement Damages Present in Diagnostic and Behavioral Markets NEW YORK, NY, Jan. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences,...
Parallax Health Sciences Announces Acquisition of Minority Interest In Global Career Networks
September 19, 2019 13:18 ET
|
Parallax Health Sciences, Inc.
SANTA MONICA, CA, Sept. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare...
Parallax Health Sciences Announces Licensing Agreement With HealthPointe Solutions
July 18, 2019 10:23 ET
|
Parallax Health Sciences, Inc.
Cognitive Artificial Intelligence and Data Analytics Combined with Outcomes Optimization for the Healthcare Market SANTA MONICA, CA, July 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax...
Parallax Health Sciences Deemed Prevailing Party and Anticipates Impending Judgment to Collect Recovery of Prior Attorney Fees and Expenses Incurred in Relation to Melamed Rescission Matter
June 17, 2019 09:24 ET
|
Parallax Health Sciences, Inc.
SANTA MONICA, CA, June 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare...
Parallax Health Sciences, Inc. Provides First Half 2019 Shareholder Update
June 11, 2019 07:00 ET
|
Parallax Health Sciences, Inc.
Company Completes Corporate Realignment Program to Focus on Generating Revenues from Point of Care Businesses and Intellectual Property Monetization SANTA MONICA, CA, June 11, 2019 (GLOBE...